Global HPV Genetically Engineered Vaccine Market Growth 2026-2032

October 2026 | 92 pages | ID: GF150B1930C8EN
LP Information

Abstracts

The global HPV Genetically Engineered Vaccine market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LP Information, Inc. (LPI) ' newest research report, the “HPV Genetically Engineered Vaccine Industry Forecast” looks at past sales and reviews total world HPV Genetically Engineered Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected HPV Genetically Engineered Vaccine sales for 2026 through 2032. With HPV Genetically Engineered Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world HPV Genetically Engineered Vaccine industry.

This Insight Report provides a comprehensive analysis of the global HPV Genetically Engineered Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on HPV Genetically Engineered Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global HPV Genetically Engineered Vaccine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for HPV Genetically Engineered Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global HPV Genetically Engineered Vaccine.

This report presents a comprehensive overview, market shares, and growth opportunities of HPV Genetically Engineered Vaccine market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Bivalent HPV Vaccine
• Quadrivalent HPV Vaccine
• 9-valent HPV Vaccine

Segmentation by Application:

• Male
• Female

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Merck & Co., Inc.
• GSK
• Walvax Biotechnology Co.,Ltd.
• Beijing Wantai Biological Pharmacy Enterprise CO.,LTD.
• Sanofi Pasteur
• Serum Institute
• Shanghai Zerun Biological Technology Co., Ltd.
• Shanghai Bovax Biotechnology Co., Ltd.
• Beijing Health Guard Biotechnology Inc.
• Jiangsu Recbio Technology Co., Ltd.

Key Questions Addressed in this Report

• What is the 10-year outlook for the global HPV Genetically Engineered Vaccine market?
• What factors are driving HPV Genetically Engineered Vaccine market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do HPV Genetically Engineered Vaccine market opportunities vary by end market size?
• How does HPV Genetically Engineered Vaccine break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global HPV Genetically Engineered Vaccine Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for HPV Genetically Engineered Vaccine by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for HPV Genetically Engineered Vaccine by Country/Region, 2021, 2025 & 2032
2.2 HPV Genetically Engineered Vaccine Segment by Type
  2.2.1 Bivalent HPV Vaccine
  2.2.2 Quadrivalent HPV Vaccine
  2.2.3 9-valent HPV Vaccine
  2.2.4 HPV Genetically Engineered Vaccine Sales by Type
    2.2.4.1 Global HPV Genetically Engineered Vaccine Sales Market Share by Type (2021-2026)
    2.2.4.2 Global HPV Genetically Engineered Vaccine Revenue and Market Share by Type (2021-2026)
    2.2.4.3 Global HPV Genetically Engineered Vaccine Sale Price by Type (2021-2026)
2.3 HPV Genetically Engineered Vaccine Segment by Application
  2.3.1 Male
  2.3.2 Female
  2.3.3 HPV Genetically Engineered Vaccine Sales by Application
    2.3.3.1 Global HPV Genetically Engineered Vaccine Sale Market Share by Application (2021-2026)
    2.3.3.2 Global HPV Genetically Engineered Vaccine Revenue and Market Share by Application (2021-2026)
    2.3.3.3 Global HPV Genetically Engineered Vaccine Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global HPV Genetically Engineered Vaccine Breakdown Data by Company
  3.1.1 Global HPV Genetically Engineered Vaccine Annual Sales by Company (2021-2026)
  3.1.2 Global HPV Genetically Engineered Vaccine Sales Market Share by Company (2021-2026)
3.2 Global HPV Genetically Engineered Vaccine Annual Revenue by Company (2021-2026)
  3.2.1 Global HPV Genetically Engineered Vaccine Revenue by Company (2021-2026)
  3.2.2 Global HPV Genetically Engineered Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global HPV Genetically Engineered Vaccine Sale Price by Company
3.4 Key Manufacturers HPV Genetically Engineered Vaccine Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers HPV Genetically Engineered Vaccine Product Location Distribution
  3.4.2 Players HPV Genetically Engineered Vaccine Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR HPV GENETICALLY ENGINEERED VACCINE BY GEOGRAPHIC REGION

4.1 World Historic HPV Genetically Engineered Vaccine Market Size by Geographic Region (2021-2026)
  4.1.1 Global HPV Genetically Engineered Vaccine Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global HPV Genetically Engineered Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic HPV Genetically Engineered Vaccine Market Size by Country/Region (2021-2026)
  4.2.1 Global HPV Genetically Engineered Vaccine Annual Sales by Country/Region (2021-2026)
  4.2.2 Global HPV Genetically Engineered Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas HPV Genetically Engineered Vaccine Sales Growth
4.4 APAC HPV Genetically Engineered Vaccine Sales Growth
4.5 Europe HPV Genetically Engineered Vaccine Sales Growth
4.6 Middle East & Africa HPV Genetically Engineered Vaccine Sales Growth

5 AMERICAS

5.1 Americas HPV Genetically Engineered Vaccine Sales by Country
  5.1.1 Americas HPV Genetically Engineered Vaccine Sales by Country (2021-2026)
  5.1.2 Americas HPV Genetically Engineered Vaccine Revenue by Country (2021-2026)
5.2 Americas HPV Genetically Engineered Vaccine Sales by Type (2021-2026)
5.3 Americas HPV Genetically Engineered Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC HPV Genetically Engineered Vaccine Sales by Region
  6.1.1 APAC HPV Genetically Engineered Vaccine Sales by Region (2021-2026)
  6.1.2 APAC HPV Genetically Engineered Vaccine Revenue by Region (2021-2026)
6.2 APAC HPV Genetically Engineered Vaccine Sales by Type (2021-2026)
6.3 APAC HPV Genetically Engineered Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe HPV Genetically Engineered Vaccine by Country
  7.1.1 Europe HPV Genetically Engineered Vaccine Sales by Country (2021-2026)
  7.1.2 Europe HPV Genetically Engineered Vaccine Revenue by Country (2021-2026)
7.2 Europe HPV Genetically Engineered Vaccine Sales by Type (2021-2026)
7.3 Europe HPV Genetically Engineered Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa HPV Genetically Engineered Vaccine by Country
  8.1.1 Middle East & Africa HPV Genetically Engineered Vaccine Sales by Country (2021-2026)
  8.1.2 Middle East & Africa HPV Genetically Engineered Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa HPV Genetically Engineered Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa HPV Genetically Engineered Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of HPV Genetically Engineered Vaccine
10.3 Manufacturing Process Analysis of HPV Genetically Engineered Vaccine
10.4 Industry Chain Structure of HPV Genetically Engineered Vaccine

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 HPV Genetically Engineered Vaccine Distributors
11.3 HPV Genetically Engineered Vaccine Customer

12 WORLD FORECAST REVIEW FOR HPV GENETICALLY ENGINEERED VACCINE BY GEOGRAPHIC REGION

12.1 Global HPV Genetically Engineered Vaccine Market Size Forecast by Region
  12.1.1 Global HPV Genetically Engineered Vaccine Forecast by Region (2027-2032)
  12.1.2 Global HPV Genetically Engineered Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global HPV Genetically Engineered Vaccine Forecast by Type (2027-2032)
12.7 Global HPV Genetically Engineered Vaccine Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 Merck & Co., Inc.
  13.1.1 Merck & Co., Inc. Company Information
  13.1.2 Merck & Co., Inc. HPV Genetically Engineered Vaccine Product Portfolios and Specifications
  13.1.3 Merck & Co., Inc. HPV Genetically Engineered Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Merck & Co., Inc. Main Business Overview
  13.1.5 Merck & Co., Inc. Latest Developments
13.2 GSK
  13.2.1 GSK Company Information
  13.2.2 GSK HPV Genetically Engineered Vaccine Product Portfolios and Specifications
  13.2.3 GSK HPV Genetically Engineered Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 GSK Main Business Overview
  13.2.5 GSK Latest Developments
13.3 Walvax Biotechnology Co.,Ltd.
  13.3.1 Walvax Biotechnology Co.,Ltd. Company Information
  13.3.2 Walvax Biotechnology Co.,Ltd. HPV Genetically Engineered Vaccine Product Portfolios and Specifications
  13.3.3 Walvax Biotechnology Co.,Ltd. HPV Genetically Engineered Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 Walvax Biotechnology Co.,Ltd. Main Business Overview
  13.3.5 Walvax Biotechnology Co.,Ltd. Latest Developments
13.4 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD.
  13.4.1 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Company Information
  13.4.2 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. HPV Genetically Engineered Vaccine Product Portfolios and Specifications
  13.4.3 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. HPV Genetically Engineered Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Main Business Overview
  13.4.5 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Latest Developments
13.5 Sanofi Pasteur
  13.5.1 Sanofi Pasteur Company Information
  13.5.2 Sanofi Pasteur HPV Genetically Engineered Vaccine Product Portfolios and Specifications
  13.5.3 Sanofi Pasteur HPV Genetically Engineered Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 Sanofi Pasteur Main Business Overview
  13.5.5 Sanofi Pasteur Latest Developments
13.6 Serum Institute
  13.6.1 Serum Institute Company Information
  13.6.2 Serum Institute HPV Genetically Engineered Vaccine Product Portfolios and Specifications
  13.6.3 Serum Institute HPV Genetically Engineered Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  13.6.4 Serum Institute Main Business Overview
  13.6.5 Serum Institute Latest Developments
13.7 Shanghai Zerun Biological Technology Co., Ltd.
  13.7.1 Shanghai Zerun Biological Technology Co., Ltd. Company Information
  13.7.2 Shanghai Zerun Biological Technology Co., Ltd. HPV Genetically Engineered Vaccine Product Portfolios and Specifications
  13.7.3 Shanghai Zerun Biological Technology Co., Ltd. HPV Genetically Engineered Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  13.7.4 Shanghai Zerun Biological Technology Co., Ltd. Main Business Overview
  13.7.5 Shanghai Zerun Biological Technology Co., Ltd. Latest Developments
13.8 Shanghai Bovax Biotechnology Co., Ltd.
  13.8.1 Shanghai Bovax Biotechnology Co., Ltd. Company Information
  13.8.2 Shanghai Bovax Biotechnology Co., Ltd. HPV Genetically Engineered Vaccine Product Portfolios and Specifications
  13.8.3 Shanghai Bovax Biotechnology Co., Ltd. HPV Genetically Engineered Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  13.8.4 Shanghai Bovax Biotechnology Co., Ltd. Main Business Overview
  13.8.5 Shanghai Bovax Biotechnology Co., Ltd. Latest Developments
13.9 Beijing Health Guard Biotechnology Inc.
  13.9.1 Beijing Health Guard Biotechnology Inc. Company Information
  13.9.2 Beijing Health Guard Biotechnology Inc. HPV Genetically Engineered Vaccine Product Portfolios and Specifications
  13.9.3 Beijing Health Guard Biotechnology Inc. HPV Genetically Engineered Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  13.9.4 Beijing Health Guard Biotechnology Inc. Main Business Overview
  13.9.5 Beijing Health Guard Biotechnology Inc. Latest Developments
13.10 Jiangsu Recbio Technology Co., Ltd.
  13.10.1 Jiangsu Recbio Technology Co., Ltd. Company Information
  13.10.2 Jiangsu Recbio Technology Co., Ltd. HPV Genetically Engineered Vaccine Product Portfolios and Specifications
  13.10.3 Jiangsu Recbio Technology Co., Ltd. HPV Genetically Engineered Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  13.10.4 Jiangsu Recbio Technology Co., Ltd. Main Business Overview
  13.10.5 Jiangsu Recbio Technology Co., Ltd. Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. HPV Genetically Engineered Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. HPV Genetically Engineered Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Bivalent HPV Vaccine
Table 4. Major Players of Quadrivalent HPV Vaccine
Table 5. Major Players of 9-valent HPV Vaccine
Table 6. Global HPV Genetically Engineered Vaccine Sales by Type (2021-2026) & (K Units)
Table 7. Global HPV Genetically Engineered Vaccine Sales Market Share by Type (2021-2026)
Table 8. Global HPV Genetically Engineered Vaccine Revenue by Type (2021-2026) & ($ million)
Table 9. Global HPV Genetically Engineered Vaccine Revenue Market Share by Type (2021-2026)
Table 10. Global HPV Genetically Engineered Vaccine Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global HPV Genetically Engineered Vaccine Sale by Application (2021-2026) & (K Units)
Table 12. Global HPV Genetically Engineered Vaccine Sale Market Share by Application (2021-2026)
Table 13. Global HPV Genetically Engineered Vaccine Revenue by Application (2021-2026) & ($ million)
Table 14. Global HPV Genetically Engineered Vaccine Revenue Market Share by Application (2021-2026)
Table 15. Global HPV Genetically Engineered Vaccine Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global HPV Genetically Engineered Vaccine Sales by Company (2021-2026) & (K Units)
Table 17. Global HPV Genetically Engineered Vaccine Sales Market Share by Company (2021-2026)
Table 18. Global HPV Genetically Engineered Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 19. Global HPV Genetically Engineered Vaccine Revenue Market Share by Company (2021-2026)
Table 20. Global HPV Genetically Engineered Vaccine Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers HPV Genetically Engineered Vaccine Producing Area Distribution and Sales Area
Table 22. Players HPV Genetically Engineered Vaccine Products Offered
Table 23. HPV Genetically Engineered Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global HPV Genetically Engineered Vaccine Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global HPV Genetically Engineered Vaccine Sales Market Share Geographic Region (2021-2026)
Table 28. Global HPV Genetically Engineered Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global HPV Genetically Engineered Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global HPV Genetically Engineered Vaccine Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global HPV Genetically Engineered Vaccine Sales Market Share by Country/Region (2021-2026)
Table 32. Global HPV Genetically Engineered Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global HPV Genetically Engineered Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas HPV Genetically Engineered Vaccine Sales by Country (2021-2026) & (K Units)
Table 35. Americas HPV Genetically Engineered Vaccine Sales Market Share by Country (2021-2026)
Table 36. Americas HPV Genetically Engineered Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas HPV Genetically Engineered Vaccine Sales by Type (2021-2026) & (K Units)
Table 38. Americas HPV Genetically Engineered Vaccine Sales by Application (2021-2026) & (K Units)
Table 39. APAC HPV Genetically Engineered Vaccine Sales by Region (2021-2026) & (K Units)
Table 40. APAC HPV Genetically Engineered Vaccine Sales Market Share by Region (2021-2026)
Table 41. APAC HPV Genetically Engineered Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC HPV Genetically Engineered Vaccine Sales by Type (2021-2026) & (K Units)
Table 43. APAC HPV Genetically Engineered Vaccine Sales by Application (2021-2026) & (K Units)
Table 44. Europe HPV Genetically Engineered Vaccine Sales by Country (2021-2026) & (K Units)
Table 45. Europe HPV Genetically Engineered Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe HPV Genetically Engineered Vaccine Sales by Type (2021-2026) & (K Units)
Table 47. Europe HPV Genetically Engineered Vaccine Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa HPV Genetically Engineered Vaccine Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa HPV Genetically Engineered Vaccine Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa HPV Genetically Engineered Vaccine Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa HPV Genetically Engineered Vaccine Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of HPV Genetically Engineered Vaccine
Table 53. Key Market Challenges & Risks of HPV Genetically Engineered Vaccine
Table 54. Key Industry Trends of HPV Genetically Engineered Vaccine
Table 55. HPV Genetically Engineered Vaccine Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. HPV Genetically Engineered Vaccine Distributors List
Table 58. HPV Genetically Engineered Vaccine Customer List
Table 59. Global HPV Genetically Engineered Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global HPV Genetically Engineered Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas HPV Genetically Engineered Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas HPV Genetically Engineered Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC HPV Genetically Engineered Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC HPV Genetically Engineered Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe HPV Genetically Engineered Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe HPV Genetically Engineered Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa HPV Genetically Engineered Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa HPV Genetically Engineered Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global HPV Genetically Engineered Vaccine Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global HPV Genetically Engineered Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global HPV Genetically Engineered Vaccine Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global HPV Genetically Engineered Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Merck & Co., Inc. Basic Information, HPV Genetically Engineered Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 74. Merck & Co., Inc. HPV Genetically Engineered Vaccine Product Portfolios and Specifications
Table 75. Merck & Co., Inc. HPV Genetically Engineered Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Merck & Co., Inc. Main Business
Table 77. Merck & Co., Inc. Latest Developments
Table 78. GSK Basic Information, HPV Genetically Engineered Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. GSK HPV Genetically Engineered Vaccine Product Portfolios and Specifications
Table 80. GSK HPV Genetically Engineered Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. GSK Main Business
Table 82. GSK Latest Developments
Table 83. Walvax Biotechnology Co.,Ltd. Basic Information, HPV Genetically Engineered Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Walvax Biotechnology Co.,Ltd. HPV Genetically Engineered Vaccine Product Portfolios and Specifications
Table 85. Walvax Biotechnology Co.,Ltd. HPV Genetically Engineered Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Walvax Biotechnology Co.,Ltd. Main Business
Table 87. Walvax Biotechnology Co.,Ltd. Latest Developments
Table 88. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Basic Information, HPV Genetically Engineered Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. HPV Genetically Engineered Vaccine Product Portfolios and Specifications
Table 90. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. HPV Genetically Engineered Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Main Business
Table 92. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Latest Developments
Table 93. Sanofi Pasteur Basic Information, HPV Genetically Engineered Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Sanofi Pasteur HPV Genetically Engineered Vaccine Product Portfolios and Specifications
Table 95. Sanofi Pasteur HPV Genetically Engineered Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Sanofi Pasteur Main Business
Table 97. Sanofi Pasteur Latest Developments
Table 98. Serum Institute Basic Information, HPV Genetically Engineered Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. Serum Institute HPV Genetically Engineered Vaccine Product Portfolios and Specifications
Table 100. Serum Institute HPV Genetically Engineered Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Serum Institute Main Business
Table 102. Serum Institute Latest Developments
Table 103. Shanghai Zerun Biological Technology Co., Ltd. Basic Information, HPV Genetically Engineered Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Shanghai Zerun Biological Technology Co., Ltd. HPV Genetically Engineered Vaccine Product Portfolios and Specifications
Table 105. Shanghai Zerun Biological Technology Co., Ltd. HPV Genetically Engineered Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Shanghai Zerun Biological Technology Co., Ltd. Main Business
Table 107. Shanghai Zerun Biological Technology Co., Ltd. Latest Developments
Table 108. Shanghai Bovax Biotechnology Co., Ltd. Basic Information, HPV Genetically Engineered Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Shanghai Bovax Biotechnology Co., Ltd. HPV Genetically Engineered Vaccine Product Portfolios and Specifications
Table 110. Shanghai Bovax Biotechnology Co., Ltd. HPV Genetically Engineered Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Shanghai Bovax Biotechnology Co., Ltd. Main Business
Table 112. Shanghai Bovax Biotechnology Co., Ltd. Latest Developments
Table 113. Beijing Health Guard Biotechnology Inc. Basic Information, HPV Genetically Engineered Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. Beijing Health Guard Biotechnology Inc. HPV Genetically Engineered Vaccine Product Portfolios and Specifications
Table 115. Beijing Health Guard Biotechnology Inc. HPV Genetically Engineered Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Beijing Health Guard Biotechnology Inc. Main Business
Table 117. Beijing Health Guard Biotechnology Inc. Latest Developments
Table 118. Jiangsu Recbio Technology Co., Ltd. Basic Information, HPV Genetically Engineered Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. Jiangsu Recbio Technology Co., Ltd. HPV Genetically Engineered Vaccine Product Portfolios and Specifications
Table 120. Jiangsu Recbio Technology Co., Ltd. HPV Genetically Engineered Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Jiangsu Recbio Technology Co., Ltd. Main Business
Table 122. Jiangsu Recbio Technology Co., Ltd. Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of HPV Genetically Engineered Vaccine
Figure 2. HPV Genetically Engineered Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global HPV Genetically Engineered Vaccine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global HPV Genetically Engineered Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. HPV Genetically Engineered Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. HPV Genetically Engineered Vaccine Sales Market Share by Country/Region (2025)
Figure 10. HPV Genetically Engineered Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Bivalent HPV Vaccine
Figure 12. Product Picture of Quadrivalent HPV Vaccine
Figure 13. Product Picture of 9-valent HPV Vaccine
Figure 14. Global HPV Genetically Engineered Vaccine Sales Market Share by Type in 2026
Figure 15. Global HPV Genetically Engineered Vaccine Revenue Market Share by Type (2021-2026)
Figure 16. HPV Genetically Engineered Vaccine Consumed in Male
Figure 17. Global HPV Genetically Engineered Vaccine Market: Male (2021-2026) & (K Units)
Figure 18. HPV Genetically Engineered Vaccine Consumed in Female
Figure 19. Global HPV Genetically Engineered Vaccine Market: Female (2021-2026) & (K Units)
Figure 20. Global HPV Genetically Engineered Vaccine Sale Market Share by Application (2025)
Figure 21. Global HPV Genetically Engineered Vaccine Revenue Market Share by Application in 2026
Figure 22. HPV Genetically Engineered Vaccine Sales by Company in 2026 (K Units)
Figure 23. Global HPV Genetically Engineered Vaccine Sales Market Share by Company in 2026
Figure 24. HPV Genetically Engineered Vaccine Revenue by Company in 2026 ($ millions)
Figure 25. Global HPV Genetically Engineered Vaccine Revenue Market Share by Company in 2026
Figure 26. Global HPV Genetically Engineered Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 27. Global HPV Genetically Engineered Vaccine Revenue Market Share by Geographic Region in 2026
Figure 28. Americas HPV Genetically Engineered Vaccine Sales 2021-2026 (K Units)
Figure 29. Americas HPV Genetically Engineered Vaccine Revenue 2021-2026 ($ millions)
Figure 30. APAC HPV Genetically Engineered Vaccine Sales 2021-2026 (K Units)
Figure 31. APAC HPV Genetically Engineered Vaccine Revenue 2021-2026 ($ millions)
Figure 32. Europe HPV Genetically Engineered Vaccine Sales 2021-2026 (K Units)
Figure 33. Europe HPV Genetically Engineered Vaccine Revenue 2021-2026 ($ millions)
Figure 34. Middle East & Africa HPV Genetically Engineered Vaccine Sales 2021-2026 (K Units)
Figure 35. Middle East & Africa HPV Genetically Engineered Vaccine Revenue 2021-2026 ($ millions)
Figure 36. Americas HPV Genetically Engineered Vaccine Sales Market Share by Country in 2026
Figure 37. Americas HPV Genetically Engineered Vaccine Revenue Market Share by Country (2021-2026)
Figure 38. Americas HPV Genetically Engineered Vaccine Sales Market Share by Type (2021-2026)
Figure 39. Americas HPV Genetically Engineered Vaccine Sales Market Share by Application (2021-2026)
Figure 40. United States HPV Genetically Engineered Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 41. Canada HPV Genetically Engineered Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 42. Mexico HPV Genetically Engineered Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 43. Brazil HPV Genetically Engineered Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 44. APAC HPV Genetically Engineered Vaccine Sales Market Share by Region in 2026
Figure 45. APAC HPV Genetically Engineered Vaccine Revenue Market Share by Region (2021-2026)
Figure 46. APAC HPV Genetically Engineered Vaccine Sales Market Share by Type (2021-2026)
Figure 47. APAC HPV Genetically Engineered Vaccine Sales Market Share by Application (2021-2026)
Figure 48. China HPV Genetically Engineered Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 49. Japan HPV Genetically Engineered Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 50. South Korea HPV Genetically Engineered Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. Southeast Asia HPV Genetically Engineered Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. India HPV Genetically Engineered Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. Australia HPV Genetically Engineered Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. China Taiwan HPV Genetically Engineered Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 55. Europe HPV Genetically Engineered Vaccine Sales Market Share by Country in 2026
Figure 56. Europe HPV Genetically Engineered Vaccine Revenue Market Share by Country (2021-2026)
Figure 57. Europe HPV Genetically Engineered Vaccine Sales Market Share by Type (2021-2026)
Figure 58. Europe HPV Genetically Engineered Vaccine Sales Market Share by Application (2021-2026)
Figure 59. Germany HPV Genetically Engineered Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 60. France HPV Genetically Engineered Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 61. UK HPV Genetically Engineered Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. Italy HPV Genetically Engineered Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. Russia HPV Genetically Engineered Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 64. Middle East & Africa HPV Genetically Engineered Vaccine Sales Market Share by Country (2021-2026)
Figure 65. Middle East & Africa HPV Genetically Engineered Vaccine Sales Market Share by Type (2021-2026)
Figure 66. Middle East & Africa HPV Genetically Engineered Vaccine Sales Market Share by Application (2021-2026)
Figure 67. Egypt HPV Genetically Engineered Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 68. South Africa HPV Genetically Engineered Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 69. Israel HPV Genetically Engineered Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. Turkey HPV Genetically Engineered Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. GCC Countries HPV Genetically Engineered Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of HPV Genetically Engineered Vaccine in 2026
Figure 73. Manufacturing Process Analysis of HPV Genetically Engineered Vaccine
Figure 74. Industry Chain Structure of HPV Genetically Engineered Vaccine
Figure 75. Channels of Distribution
Figure 76. Global HPV Genetically Engineered Vaccine Sales Market Forecast by Region (2027-2032)
Figure 77. Global HPV Genetically Engineered Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 78. Global HPV Genetically Engineered Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 79. Global HPV Genetically Engineered Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 80. Global HPV Genetically Engineered Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 81. Global HPV Genetically Engineered Vaccine Revenue Market Share Forecast by Application (2027-2032)